Skip to content

Press Releases

Date Title
Jul 22, 2021 Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
Jul 13, 2021 Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
Jun 1, 2021 Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
May 27, 2021 Illumina To Webcast Upcoming Investor Conference
May 17, 2021 Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development
Apr 29, 2021 Illumina To Webcast Upcoming Investor Conference
Apr 29, 2021 Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
Apr 28, 2021 Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
Apr 27, 2021 Illumina Reports Financial Results for First Quarter of Fiscal Year 2021
Apr 22, 2021 Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
Apr 20, 2021 Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Apr 5, 2021 Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021
Mar 30, 2021 Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Mar 18, 2021 Illumina Announces Board Changes
Mar 11, 2021 Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
Mar 5, 2021 Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia
Feb 11, 2021 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2020
Feb 10, 2021 Illumina to Webcast Upcoming Investor Conference Presentations
Feb 8, 2021 Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
Feb 4, 2021 Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium
Jan 31, 2021 Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
Jan 25, 2021 Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
Jan 20, 2021 Illumina Wins Patent Infringement Suit against BGI in the UK
Jan 11, 2021 New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale
Jan 11, 2021 Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling
Jan 5, 2021 Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure